|4Nov 21, 1:17 PM ET

Deschenes Roger P. 4

4 · IMPLANT SCIENCES CORP · Filed Nov 21, 2012

Insider Transaction Report

Form 4
Period: 2012-11-20
Deschenes Roger P.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2012-11-20$0.17/sh+75,000$12,750100,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-11-20+25,0000 total
    Exercise: $0.20Exp: 2013-12-30Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-11-20$0.20/sh+25,000$5,00025,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-11-20+75,0000 total
    Exercise: $0.17Exp: 2014-02-05Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]These options are exercisable as to 4,196 shares on December 30, 2008, another 10,402 shares on December 30, 2009 with the remaining 10,402 shares exercisable on December 30, 2010.
  • [F2]These options are exercisable in three equal annual installments of 25,000 shares commencing February 5, 2009.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT